Therapeutic uses of microencapsulated genetically engineered cells. (Q45887483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Therapeutic uses of microencapsulated genetically engineered cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

T M Chang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

Trends in Molecular Medicine

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

221-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

SEMIPERMEABLE MICROCAPSULES

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Semipermeable aqueous microcapsules. I. Preparation and properties

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Xenotransplantation of cells and tissues: application to a range of diseases, from diabetes to Alzheimer's

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Diffusion of univalent ions across the lamellae of swollen phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Growth retardation--an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Transplantation of Xenogeneic Cells Secreting β-Endorphin for Pain Treatment: Analysis of the Ability of Components of Complement to Penetrate through Polymer Capsules

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Implantable Biohybrid Artificial Organs

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Transport characterization of membranes for immunoisolation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901246-5

7 January 2021

10.1016/S1357-4310(98)01246-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9612802%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference